World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
29801
World Ranking
12669
National Ranking
6479

David A. Luckenbaugh publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David A. Luckenbaugh sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 193 publications — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David A. Luckenbaugh D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David A. Luckenbaugh sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David A. Luckenbaugh is affiliated with the National Institutes of Health in the United States. Their research spans several areas within medicine, with a focus on pharmacology, biological psychiatry, experimental and cognitive psychology, psychiatry and mental health, and pediatrics, perinatology, and child health.

The scientist has contributed to topics including:

  • Treatment of Major Depression
  • Tryptophan and brain disorders
  • Mental Health Research Topics
  • Bipolar Disorder and Treatment
  • Pharmacological Effects and Toxicity Studies
  • Adolescent and Pediatric Healthcare

David A. Luckenbaugh's recent published papers emphasize clinical and pharmacological investigations. These include:

  • The effects of ketamine on typical and atypical depressive symptoms, 2020, Acta Psychiatrica Scandinavica
  • A Double-Blind, Randomized, Placebo-Controlled 4-Week Study on the Efficacy and Safety of the Purinergic Agents Allopurinol and Dipyridamole Adjunctive to Lithium in Acute Bipolar Mania, 2020, UNC Libraries

The frequent co-authors with whom they have collaborated consist of:

  • Carlos A. Zarate
  • Lawrence T. Park
  • Steven Pennybaker
  • Matthew Hopkins
  • Ioline D. Henter

The primary venues where Luckenbaugh has published their research include:

  • Acta Psychiatrica Scandinavica
  • UNC Libraries

Best Publications

  • A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression

    Carlos A. Zarate;Jaskaran B. Singh;Paul J. Carlson;Nancy E. Brutsche

  • A Randomized Add-on Trial of an N-methyl-d-aspartate Antagonist in Treatment-Resistant Bipolar Depression

    Nancy Diazgranados;Lobna Ibrahim;Nancy E. Brutsche;Andrew Newberg

  • Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.

    Carlos A. Zarate;Nancy E. Brutsche;Lobna Ibrahim;Jose Franco-Chaves

  • A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders.

    Mark A. Frye;Terence A. Ketter;Timothy A. Kimbrell;Timothy A. Kimbrell;Robert T. Dunn

  • Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.

    Nancy DiazGranados;Lobna A. Ibrahim;Nancy E. Brutsche;Rezvan Ameli

  • Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment.

    Meena Vythilingam;Eric Vermetten;George M Anderson;David Luckenbaugh

  • Reward improves long-term retention of a motor memory through induction of offline memory gains

    Mitsunari Abe;Heidi Schambra;Eric M. Wassermann;Dave Luckenbaugh

  • Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH Life Chart Method

    Robert M. Post;Kirk D. Denicoff;Gabriele S. Leverich;Lori L. Altshuler

  • Reduced Serotonin Type 1A Receptor Binding in Panic Disorder

    Alexander Neumeister;Earle Bain;Allison C. Nugent;Richard E. Carson

  • Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network.

    Gabriele S. Leverich;Lori L. Altshuler;Mark A. Frye;Trisha Suppes

  • A Double-Blind, Placebo-Controlled Study of Memantine in the Treatment of Major Depression

    Carlos A. Zarate;Jaskaran B. Singh;Jorge A. Quiroz;Georgette De Jesus

  • Evidence for continuing neuropsychological impairments in depression

    Petra Weiland-Fiedler;Kristine Erickson;Tracy Waldeck;David A. Luckenbaugh

  • Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder

    Ralph W. Kupka;Lori L. Altshuler;Willem A. Nolen;Trisha Suppes

  • Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood

    Robert M. Post;Gabriele S. Leverich;Ralph W. Kupka;Paul E. Keck

  • Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.

    Carlos A Zarate;Jennifer L Payne;Jaskaran Singh;Jorge A Quiroz

  • An open-label trial of riluzole in patients with treatment-resistant major depression.

    Carlos A. Zarate;Jennifer L. Payne;Jorge Quiroz;Jonathan Sporn

  • Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study

    Lobna Ibrahim;Nancy DiazGranados;Nancy DiazGranados;Jose Franco-Chaves;Nancy Brutsche

  • Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects.

    Alexander Neumeister;Suzanne Wood;Omer Bonne;Allison C. Nugent

  • Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls.

    Alexander Neumeister;Allison C. Nugent;Tracy Waldeck;Marilla Geraci

  • An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression

    Carlos A. Zarate;Jorge A. Quiroz;Jaskaran B. Singh;Kirk D. Denicoff

Frequent Co-Authors

Carlos A. Zarate
Carlos A. Zarate National Institutes of Health
Wayne C. Drevets
Wayne C. Drevets Johnson & Johnson (United States)
Dennis S. Charney
Dennis S. Charney Icahn School of Medicine at Mount Sinai
Robert M. Post
Robert M. Post George Washington University
Mark J. Niciu
Mark J. Niciu University of Iowa
Rodrigo Machado-Vieira
Rodrigo Machado-Vieira The University of Texas Health Science Center at Houston
Alexander Neumeister
Alexander Neumeister Independent Scientist / Consultant, US
Elizabeth D. Ballard
Elizabeth D. Ballard National Institutes of Health
Mark A. Frye
Mark A. Frye University of California, Los Angeles
Lori L. Altshuler
Lori L. Altshuler University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring medical professionals have a variety of online degree choices and career pathways in health care. Many students in the USA start with related fields before or while pursuing a medical degree. For those interested in the administrative side of healthcare, earning a him bachelor's degree online can open doors to managing patient data and health information systems.

Another popular option is pursuing the cheapest medical billing and coding online courses. This career path is vital for accurate patient records and insurance processing. For those aiming for direct patient care but seeking flexibility, there are many cheapest fnp programs that help students become Family Nurse Practitioners via online learning.

Lastly, if you want to become a registered nurse, a wide range of online nursing courses offer affordable entry points. These online degrees and certifications provide diverse opportunities to enter or advance within the healthcare field, especially for those balancing work, study, and family commitments.

Best Scientists Citing David A. Luckenbaugh

Trending Scientists

Recently Published Articles